Cover Image
市場調查報告書

膠原蛋白:開發平台分析

Collagens - Pipeline Review, 2015

出版商 GlobalData 商品編碼 341584
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
膠原蛋白:開發平台分析 Collagens - Pipeline Review, 2015
出版日期: 2015年09月04日 內容資訊: 英文 95 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的膠原蛋白之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 膠原蛋白概要

第3章 開發中的產品

  • 膠原蛋白 - 各開發階段的開發中產品
  • 膠原蛋白 - 各市場區隔的開發中產品
  • 膠原蛋白 -國家 (地區) 別的開發中產品
  • 膠原蛋白 - 法規別的開發中產品
  • 膠原蛋白 - 核准時期 (估計) 別的開發中產品
  • 膠原蛋白 - 現在進行中的臨床實驗

第4章 膠原蛋白 - 正在開發的開發中產品:各企業

  • 膠原蛋白企業 - 各開發階段的開發中產品
  • 膠原蛋白 - 各開發階段的開發中產品

第5章 膠原蛋白企業與產品概要

  • Advanced Medical Solutions Group plc
  • AGAM Biological Products
  • Alliqua BioMedical, Inc.
  • botiss dental GmbH
  • CollPlant Ltd.
  • Conversion Energy Enterprises
  • Covalon Technologies Ltd.
  • EternoGen, LLC
  • Holista CollTech Limited
  • Innocoll Technologies Limited
  • Jellagen Pty Ltd
  • Kyeron BV
  • Medtronic plc
  • Nanotherapeutics, Inc.
  • PlasMedica Technologies Limited
  • Shire Plc
  • Taxus Cardium Pharmaceuticals Group Inc.
  • ULURU Inc.

第6章 膠原蛋白 - 最近的趨勢

第7章 附錄

目錄
Product Code: GDME0060EPD

GlobalData's Medical Devices sector report, "Collagens - Pipeline Review, 2015" provides an overview of Collagens currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Collagens pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Collagens under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Collagens and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Collagens under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Collagens Overview

3. Products under Development

  • 3.1. Collagens - Pipeline Products by Stage of Development
  • 3.2. Collagens - Pipeline Products by Segment
  • 3.3. Collagens - Pipeline Products by Territory
  • 3.4. Collagens - Pipeline Products by Regulatory Path
  • 3.5. Collagens - Pipeline Products by Estimated Approval Date
  • 3.6. Collagens - Ongoing Clinical Trials

4. Collagens - Pipeline Products under Development by Companies

  • 4.1. Collagens Companies - Pipeline Products by Stage of Development
  • 4.2. Collagens - Pipeline Products by Stage of Development

5. Collagens Companies and Product Overview

  • 5.1. Advanced Medical Solutions Group plc Company Overview
    • 5.1.1. Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AGAM Biological Products Company Overview
    • 5.2.1. AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Alliqua BioMedical, Inc. Company Overview
    • 5.3.1. Alliqua BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. botiss dental GmbH Company Overview
    • 5.4.1. botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. CollPlant Ltd. Company Overview
    • 5.5.1. CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Conversion Energy Enterprises Company Overview
    • 5.6.1. Conversion Energy Enterprises Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Covalon Technologies Ltd. Company Overview
    • 5.7.1. Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. EternoGen, LLC Company Overview
    • 5.8.1. EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Holista CollTech Limited Company Overview
    • 5.9.1. Holista CollTech Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Innocoll Technologies Limited Company Overview
    • 5.10.1. Innocoll Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Jellagen Pty Ltd Company Overview
    • 5.11.1. Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Kyeron BV Company Overview
    • 5.12.1. Kyeron BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Medtronic plc Company Overview
    • 5.13.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Nanotherapeutics, Inc. Company Overview
    • 5.14.1. Nanotherapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. PlasMedica Technologies Limited Company Overview
    • 5.15.1. PlasMedica Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Shire Plc Company Overview
    • 5.16.1. Shire Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Taxus Cardium Pharmaceuticals Group Inc. Company Overview
    • 5.17.1. Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. ULURU Inc. Company Overview
    • 5.18.1. ULURU Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Collagens- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Collagens - Pipeline Products by Stage of Development
  • Table 2: Collagens - Pipeline Products by Segment
  • Table 3: Collagens - Pipeline Products by Territory
  • Table 4: Collagens - Pipeline Products by Regulatory Path
  • Table 5: Collagens - Pipeline Products by Estimated Approval Date
  • Table 6: Collagens - Ongoing Clinical Trials
  • Table 7: Collagens Companies - Pipeline Products by Stage of Development
  • Table 8: Collagens - Pipeline Products by Stage of Development
  • Table 9: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Reinforced Collagen - Product Status
  • Table 11: Reinforced Collagen - Product Description
  • Table 12: AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Wound Dressing Pad - Product Status
  • Table 14: Wound Dressing Pad - Product Description
  • Table 15: Alliqua BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Tissue Repair Scaffold - Product Status
  • Table 17: Tissue Repair Scaffold - Product Description
  • Table 18: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: collacone - Product Status
  • Table 20: collacone - Product Description
  • Table 21: collprotect Membrane - Product Status
  • Table 22: collprotect Membrane - Product Description
  • Table 23: Jason Collagen Fleece - Product Status
  • Table 24: Jason Collagen Fleece - Product Description
  • Table 25: Jason Membrane - Product Status
  • Table 26: Jason Membrane - Product Description
  • Table 27: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: VergenixFG - Product Status
  • Table 29: VergenixFG - Product Description
  • Table 30: VergenixWD - Product Status
  • Table 31: VergenixWD - Product Description
  • Table 32: CollPlant Ltd. - Ongoing Clinical Trials Overview
  • Table 33: VergenixWD - A Clinical Study For The Treatment Of Chronic Wounds In Diabetes Patients
  • Table 34: VergenixFG - Assessment of Vergenix Flowable Gel Product Safety and Efficacy in Treatment of Wounds
  • Table 35: Conversion Energy Enterprises Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Photoactivated Collagen Dressing - Product Status
  • Table 37: Photoactivated Collagen Dressing - Product Description
  • Table 38: Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Hemostatic Delivering FNS - Product Status
  • Table 40: Hemostatic Delivering FNS - Product Description
  • Table 41: Hemostatic Dressing Delivering PLT - Product Status
  • Table 42: Hemostatic Dressing Delivering PLT - Product Description
  • Table 43: EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Collagen Scaffold - Wound Healing - Product Status
  • Table 45: Collagen Scaffold - Wound Healing - Product Description
  • Table 46: Holista CollTech Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Ovicoll M - Product Status
  • Table 48: Ovicoll M - Product Description
  • Table 49: Innocoll Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Cogenzia - Product Status
  • Table 51: Cogenzia - Product Description
  • Table 52: CollaRx Gentamicin Surgical Implant - Product Status
  • Table 53: CollaRx Gentamicin Surgical Implant - Product Description
  • Table 54: COLLIEVA Ag - Product Status
  • Table 55: COLLIEVA Ag - Product Description
  • Table 56: DermaSIL (CM003) - Product Status
  • Table 57: DermaSIL (CM003) - Product Description
  • Table 58: Durieva - Product Status
  • Table 59: Durieva - Product Description
  • Table 60: Second Generation Collagen Matrix - Product Status
  • Table 61: Second Generation Collagen Matrix - Product Description
  • Table 62: Third Generation Collagen Matrix - Product Status
  • Table 63: Third Generation Collagen Matrix - Product Description
  • Table 64: Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Collagen-based Wound Healing Device - Product Status
  • Table 66: Collagen-based Wound Healing Device - Product Description
  • Table 67: Kyeron BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Wound Management Device - Product Status
  • Table 69: Wound Management Device - Product Description
  • Table 70: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Duratech - Abdominal Wall Reconstruction - Product Status
  • Table 72: Duratech - Abdominal Wall Reconstruction - Product Description
  • Table 73: Duratech - Hernia Repair - Product Status
  • Table 74: Duratech - Hernia Repair - Product Description
  • Table 75: Duratech - Wound Care - Product Status
  • Table 76: Duratech - Wound Care - Product Description
  • Table 77: Nanotherapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: ntSPONGE - Product Status
  • Table 79: ntSPONGE - Product Description
  • Table 80: PlasMedica Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: PlasmaPly - Burns and Wounds - Product Status
  • Table 82: PlasmaPly - Burns and Wounds - Product Description
  • Table 83: PlasmaPly - Diabetic Foot Ulcers - Product Status
  • Table 84: PlasmaPly - Diabetic Foot Ulcers - Product Description
  • Table 85: PlasmaPly - Internal Ulcers - Product Status
  • Table 86: PlasmaPly - Internal Ulcers - Product Description
  • Table 87: PlasmaPly - Military Acute Injuries - Product Status
  • Table 88: PlasmaPly - Military Acute Injuries - Product Description
  • Table 89: PlasmaPly - Pressure Ulcers - Product Status
  • Table 90: PlasmaPly - Pressure Ulcers - Product Description
  • Table 91: PlasmaPly - Skin Disorders - Product Status
  • Table 92: PlasmaPly - Skin Disorders - Product Description
  • Table 93: PlasmaPly - Venous Ulcers - Product Status
  • Table 94: PlasmaPly - Venous Ulcers - Product Description
  • Table 95: PlasmaPly Drug Delivery Matrix - Product Status
  • Table 96: PlasmaPly Drug Delivery Matrix - Product Description
  • Table 97: Shire Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Recombinant Collagen VII (rC7) - Product Status
  • Table 99: Recombinant Collagen VII (rC7) - Product Description
  • Table 100: Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: Excellagen - Expanded Structural And Functional Properties - Product Status
  • Table 102: Excellagen - Expanded Structural And Functional Properties - Product Description
  • Table 103: ULURU Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Altrazeal Collagen - Product Status
  • Table 105: Altrazeal Collagen - Product Description
  • Table 106: Glossary

List of Figures

  • Figure 1: Collagens - Pipeline Products by Stage of Development
  • Figure 2: Collagens - Pipeline Products by Segment
  • Figure 3: Collagens - Pipeline Products by Territory
  • Figure 4: Collagens - Pipeline Products by Regulatory Path
  • Figure 5: Collagens - Pipeline Products by Estimated Approval Date
  • Figure 6: Collagens - Ongoing Clinical Trials
Back to Top